Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
8 Supplements Ranked for Reversing Artery Plaque — Only One Holds UpHeart Health

8 Supplements Ranked for Reversing Artery Plaque — Only One Holds Up

In this solo episode, Simon Hill reviews eight supplements commonly promoted for reversing arterial plaque and ranks them strictly by human clinical evidence. Pure EPA omega-3 emerges as the clear frontrunner, supported by the EVAPORATE trial showing 9% plaque regression and REDUCE-IT demonstrating a 25% reduction in cardiac events. Aged garlic extract and vitamin K2 show modest but intriguing imaging data. Niacin, despite raising HDL, failed to reduce events in major trials. CoQ10, berberine, nattokinase, and pomegranate extract round out the list with limited or conflicting human evidence. Hill also shares his personal protocol after discovering early plaque in his own coronary artery, and cautions that supplements are adjuncts — never replacements — for proven lifestyle and pharmaceutical interventions.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.